| Application no. and date | 16725504.1 (espacenet) (Federated) (European Patent Register), 20160525 | | Patent/reg. no. and date | DK/EP 3302550, 20190828 | | Publication date | 20180411 | | Priority no. and date | EP 15169124, 20150526, EP 15196860, 20151127 | | EP pub. no. and date |
EP 3302550 20180411 | | Effective date | | | Applicant/owner | Incyte Corporation, 1801 Augustine Cut-Off
Wilmington
Delaware 19803
, US | | Applicant ref. no. | P70115DK01 | | Inventor | ENDELL, Jan, Barer Str. 36
80333 München, DE,
WINDERLICH, Mark, Ohlstadterstr. 8
81373 München, DE,
BOXHAMMER, Rainer, Birkenstr. 4a
83059 Kolbermoor, DE | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | | Opponent | | | IPC Class | A61K 31/505 (2006.01) , A61K 31/519 (2006.01) , A61K 39/395 (2006.01) , A61P 35/00 (2006.01) , C07K 16/28 (2006.01) | | Title | KOMBINATION AF ET ANTI-CD19 ANTISTOF OG EN BRUTONS TYROSINE KINASE-INHIBITOR OG ANVENDELSE DERAF | | Int. application no. | EP2016061744 | | Int. publication no. | WO2016189014 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
